227 related articles for article (PubMed ID: 26338995)
1. Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.
Sun H; Tang H; Xie D; Jia Z; Ma Z; Wei D; Mishra L; Gao Y; Zheng S; Xie K; Peng Z
Clin Cancer Res; 2016 Jan; 22(2):502-12. PubMed ID: 26338995
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K
Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
4. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
5. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression.
He H; Wu Z; Li S; Chen K; Wang D; Zou H; Chen H; Li Y; Liu Z; Qu C
Cancer Lett; 2020 Jan; 469():380-389. PubMed ID: 31730901
[TBL] [Abstract][Full Text] [Related]
6. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
[TBL] [Abstract][Full Text] [Related]
7. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
Tian C; Yao S; Liu L; Ding Y; Ye Q; Dong X; Gao Y; Yang N; Li Q
Int J Mol Med; 2017 Jan; 39(1):47-56. PubMed ID: 27909734
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway.
Zhu JN; Jiang L; Jiang JH; Yang X; Li XY; Zeng JX; Shi RY; Shi Y; Pan XR; Han ZP; Wei LX
Sci Rep; 2017 Jul; 7(1):4793. PubMed ID: 28684878
[TBL] [Abstract][Full Text] [Related]
9. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
[TBL] [Abstract][Full Text] [Related]
12. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.
Ninomiya T; Hayashi Y; Saijoh K; Ohta K; Yoon S; Nakabayashi H; Tamaoki T; Kasuga M; Itoh H
J Hepatol; 1996 Oct; 25(4):445-53. PubMed ID: 8912143
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z
J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505
[TBL] [Abstract][Full Text] [Related]
14. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2.
Sung MT; Hsu HT; Lee CC; Lee HC; Kuo YJ; Hua K; Hsia CY; Chi CW
Oncol Rep; 2015 Jul; 34(1):439-46. PubMed ID: 25954999
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
17. Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma.
Pang L; Xu L; Yuan C; Li X; Zhang X; Wang W; Guo X; Ouyang Y; Qiao L; Wang Z; Liu K
Mol Carcinog; 2019 Nov; 58(11):2118-2126. PubMed ID: 31465134
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
20. RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis.
Zhao Q; Cai W; Zhang X; Tian S; Zhang J; Li H; Hou C; Ma X; Chen H; Huang B; Chen D
J Biol Chem; 2017 Feb; 292(6):2143-2158. PubMed ID: 28028181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
